IDMC recommends stopping enrollment of placebo group in phase III outpatient trial of REGEN-COV Feb. 26, 2021
Altimmune initiates enrollment in phase I study of AdCOVID intranasal COVID-19 vaccine candidate Feb. 26, 2021
Data from proof-of-concept OSCAR study of otilimab in hospitalized patients with COVID-19 Feb. 26, 2021
REGN-3048 plus REGN-3051 show promise for treatment or prophylaxis of MERS-CoV infection Feb. 26, 2021
RSS